Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why 4 of Last Night’s Biggest Losers Are Still Struggling in the Light of Day

Page 1 of 2

There’s been no reprieve today for four stocks that were among the biggest losers in after-hours trading yesterday, as each gapped open lower today and continues to struggle in the harsh light of day. Let’s see what woes have afflicted these stocks and caused nightmares for its investors last night.


We’ll start with FireEye Inc. (NASDAQ:FEYE), which released an unexpectedly poor third quarter earnings report in yesterday’s after-hours session, along with weak fourth quarter guidance. While sales for the third quarter were strong at $166 million, a 45% year-over-year increase, and earnings beat estimates despite falling by 6% to a GAAP net loss of $0.88 per share, it was the internet security company’s weak guidance and billings that crushed its stock, which is down by 23.66% today. FireEye Inc. (NASDAQ:FEYE)’s billings came in at $210.6 million, 6.5% below the low-end of its guidance and even further below analysts’ estimates, while it slashed its full-year revenue and income guidance, with its projected non-GAAP net loss of $1.62 dwarfing the previous projected loss of $0.75.

Follow Fireeye Inc. (NASDAQ:FEYE)
Trade (NASDAQ:FEYE) Now!

After cresting $85 in late-February 2014, shares of FireEye Inc. (NASDAQ:FEYE) have lost over 70% of their value since and are down by 29.21% this year. Analysts and the elite hedge funds tracked by Insider Monkey were both losing confidence in the stock in advance of today’s tumble.

Whether elite hedge funds collectively like a stock or not is an important metric to consider, as these large investors show a great level of skill and expertise when it comes to picking stocks. Over the last few years equity hedge funds have trailed the market by a large margin, but that’s mostly due to their hedging and short positions, which perform poorly in a bull market. Their long positions performed far better, especially their small-cap picks, which have the potential to beat the market by 95 basis points per month on average, as our backtests showed. Our small-cap strategy involves imitating a portfolio of the 15 most popular small-cap picks among hedge funds and it has returned 102% since August 2012, beating the S&P 500 ETF (SPY) by over 53 percentage points (read more details here).

Shares of Castlight Health Inc (NYSE:CSLT) are being battered even worse than FireEye’s, losing 25.47% of their value today, despite the healthcare management services provider announcing an expanded collaboration with Anthem Inc (NYSE:ANTM) yesterday, which will include the two companies jointly promoting Castlight Health Inc (NYSE:CSLT)’s services to Anthem Inc (NYSE:ANTM)’s customers.

Follow Anthem Inc. (NYSE:ANTM)
Trade (NYSE:ANTM) Now!

It was Castlight Health Inc (NYSE:CSLT)’s third quarter earnings report that appear to have done the firm’s stock in, despite the revenue of $19.50 million and earnings of a loss of $0.17 per share being in-line with estimates. The main culprit appears to be its fourth quarter guidance of $20.7 million-to-$21 million in revenue and a non-GAAP net loss per share of $0.16-to-$0.17, which were worse than estimates. Furthermore, the stock was downgraded by Leerink Swann to ‘Market Perform’ from ‘Outperform’ following the earnings and Anthem Inc (NYSE:ANTM) collaboration announcement, though Stifel Nicolaus reiterated a ‘Buy’ rating on the stock. 16 hedge funds in our database held 7.50% of Castlight’s shares on June 30

Follow Castlight Health Inc. (NYSE:CSLT)
Trade (NYSE:CSLT) Now!

On the following page we’ll see why QUALCOMM, Inc. (NASDAQ:QCOM) and Axcelis Technologies Inc (NASDAQ:ACLS) aren’t getting any love today.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!